David S Goldstein
Overview
Explore the profile of David S Goldstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
271
Citations
8768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Mina Y, Enose-Akahata Y, Hammoud D, Videckis A, Narpala S, OConnell S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 May;
10(4).
PMID: 37147136
Background And Objectives: SARS-CoV-2 infection has been associated with a syndrome of long-term neurologic sequelae that is poorly characterized. We aimed to describe and characterize in-depth features of neurologic postacute...
22.
Goldstein D, Dill S, Sullivan P, Grabov E, Chittiboina P
Clin Auton Res
. 2023 Mar;
33(2):205-208.
PMID: 36881269
We describe a patient with neurogenic orthostatic hypotension (nOH) after brainstem neurosurgery in whom baroreflex-cardiovagal function was normal despite baroreflex-sympathoneural failure. We also cite other conditions entailing differential alterations in...
23.
24.
Goldstein D, Sharabi Y
Clin Auton Res
. 2022 Dec;
33(1):41-49.
PMID: 36507976
Purpose: In central Lewy body diseases (LBDs) such as Parkinson's disease (PD) and dementia with Lewy bodies (DLB), by the time parkinsonism or cognitive dysfunction becomes manifest, substantial central neurodegeneration...
25.
Goldstein D, Holmes C
Clin Auton Res
. 2022 Oct;
32(6):445-453.
PMID: 36208363
Purpose: F-Dopamine positron emission tomography is a validated method for identifying cardiac noradrenergic deficiency, a characteristic feature of Lewy body forms of neurogenic orthostatic hypotension; however, F-dopamine is a research...
26.
27.
Jayanthi S, Ladenheim B, Sullivan P, McCoy M, Krasnova I, Goldstein D, et al.
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36077488
Perturbations in striatal dopamine (DA) homeostasis might underlie the behavioral and pathobiological consequences of METH use disorder in humans. To identify potential consequences of long-term METH exposure, we modeled the...
28.
Mayuga K, Fedorowski A, Ricci F, Gopinathannair R, Dukes J, Gibbons C, et al.
Circ Arrhythm Electrophysiol
. 2022 Sep;
15(9):e007960.
PMID: 36074973
Sinus tachycardia (ST) is ubiquitous, but its presence outside of normal physiological triggers in otherwise healthy individuals remains a commonly encountered phenomenon in medical practice. In many cases, ST can...
29.
Goldstein D, Pekker M, Sullivan P, Isonaka R, Sharabi Y
J Am Heart Assoc
. 2022 May;
11(11):e024411.
PMID: 35621196
Background Lewy body diseases (LBDs) feature deficiency of the sympathetic neurotransmitter norepinephrine in the left ventricular myocardium and sympathetic intra-neuronal deposition of the protein alpha-synuclein (αS). LBDs therefore are autonomic...
30.
Daiwile A, Sullivan P, Jayanthi S, Goldstein D, Cadet J
Int J Mol Sci
. 2022 Apr;
23(8).
PMID: 35457170
Methamphetamine (METH) use disorder affects both sexes, with sex differences occurring in behavioral, structural, and biochemical consequences. The molecular mechanisms underlying these differences are unclear. Herein, we used a rat...